GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and The Observational and Pragmatic Research Institute (OPRI), Singapore
Test doses may underperform
When the medication is discontinued, hunger often returns more quickly, cravings may intensify, feelings of fullness after meals can fade, and portions may feel less satisfying
Upon oxidation, cardiolipin migrates to the outer membrane, where it can come into close contact with amyloidogenic proteins in the cytoplasm
GLP-Pro pairs pasteurized Akkermansia, ButyraGen and resilient Bacillus spores to nourish L-cellsthe gut messengers that naturally release GLP-1while reinforcing the intestinal barrier and short-chain fatty-acid output for balanced appetite cues, comfortable digestion and everyday metabolic wellness.*
I have been tracking data and decided to do a deep dive going back 5 yrs (Dec 2020 - Jan 2026) to see what I find